9 Hrs
Source:
الصحة والعلوم الشرق الأوسط
Source: الصحة والعلوم الشرق الأوسط
9 Hrsالصحة والعلوم الشرق الأوسط
Source: الصحة والعلوم الشرق الأوسط
9 HrsReady to play
Ready to play
An Australian study has found that medications used to treat Attention Deficit Hyperactivity Disorder (ADHD), particularly Dextamfetamine, lead to a significant decrease in children's weight during the first year of treatment. Children taking these medications lost about 3 pounds in the first three months, compared to just half a pound in children receiving Methylphenidate. The study also showed that these drugs do not impact height growth rates. The main difference lies in the greater weight loss associated with Dextamfetamine, which is an important factor to consider when selecting an appropriate treatment and monitoring the child's growth. It is estimated that around 47 million people under the age of twenty worldwide suffer from this disorder.
Notice: This Is an AI-Generated Summary
Comments (0)